Sinopep-Allsino Bio Pharmaceutical Co., Ltd.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is -1.69% vs 58.09% in Mar 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is -14.20% vs 128.95% in Mar 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "553.00",
          "val2": "562.50",
          "chgp": "-1.69%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "162.70",
          "val2": "255.40",
          "chgp": "-36.30%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "16.20",
          "val2": "12.90",
          "chgp": "25.58%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "126.90",
          "val2": "147.90",
          "chgp": "-14.20%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "294.30%",
          "val2": "324.20%",
          "chgp": "-2.99%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is 19.54% vs 57.13% in Dec 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is -18.61% vs 141.57% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,939.00",
          "val2": "1,622.10",
          "chgp": "19.54%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "761.60",
          "val2": "670.10",
          "chgp": "13.65%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "66.20",
          "val2": "35.10",
          "chgp": "88.60%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "1.90",
          "val2": "-2.80",
          "chgp": "167.86%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "325.40",
          "val2": "399.80",
          "chgp": "-18.61%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "223.00%",
          "val2": "279.30%",
          "chgp": "-5.63%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY

Mar'26

Mar'25

Change(%)

Net Sales

553.00

562.50

-1.69%

Operating Profit (PBDIT) excl Other Income

162.70

255.40

-36.30%

Interest

16.20

12.90

25.58%

Exceptional Items

0.00

0.00

Consolidate Net Profit

126.90

147.90

-14.20%

Operating Profit Margin (Excl OI)

294.30%

324.20%

-2.99%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Mar 2026 is -1.69% vs 58.09% in Mar 2025

Consolidated Net Profit

YoY Growth in quarter ended Mar 2026 is -14.20% vs 128.95% in Mar 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

1,939.00

1,622.10

19.54%

Operating Profit (PBDIT) excl Other Income

761.60

670.10

13.65%

Interest

66.20

35.10

88.60%

Exceptional Items

1.90

-2.80

167.86%

Consolidate Net Profit

325.40

399.80

-18.61%

Operating Profit Margin (Excl OI)

223.00%

279.30%

-5.63%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2025 is 19.54% vs 57.13% in Dec 2024

Consolidated Net Profit

YoY Growth in year ended Dec 2025 is -18.61% vs 141.57% in Dec 2024

All Annual Results